Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A
Clinical trial NCT02328963 · COMPLETED
Trial details
- NCT number
- NCT02328963
- Sponsor
- University Hospital, Bordeaux
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-02
- Primary completion
- 2018-10-10
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.